Semler Scientific Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Semler Scientific.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.3%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	06 Mar 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

Mar 08

Semler Scientific: Why I'm Buying

Mar 05

Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?

Mar 02

Semler's Unique Business Model Is Fueling Profitable Growth

Feb 23

Better Price For Semler Is Likely

Jan 05

Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem

Nov 12

It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers

Oct 15

Semler Scientific: Rapidly Growing Medical Device Company

Oct 14

There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump

Oct 14

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:SMLR - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2024	76	27	N/A	N/A	1
12/31/2023	68	21	21	21	N/A
9/30/2023	67	20	17	19	N/A
6/30/2023	65	18	20	22	N/A
3/31/2023	61	16	15	17	N/A
12/31/2022	57	14	15	17	N/A
9/30/2022	54	13	16	17	N/A
6/30/2022	54	13	16	17	N/A
3/31/2022	54	16	12	13	N/A
12/31/2021	53	17	15	16	N/A
9/30/2021	54	21	19	20	N/A
6/30/2021	50	22	15	16	N/A
3/31/2021	42	16	15	16	N/A
12/31/2020	39	14	14	15	N/A
9/30/2020	36	11	12	13	N/A
6/30/2020	34	14	13	14	N/A
3/31/2020	35	16	13	15	N/A
12/31/2019	33	15	11	13	N/A
9/30/2019	30	14	10	11	N/A
6/30/2019	26	7	6	8	N/A
3/31/2019	24	6	6	7	N/A
12/31/2018	21	5	4	5	N/A
9/30/2018	20	4	2	3	N/A
6/30/2018	18	2	2	2	N/A
3/31/2018	15	0	0	1	N/A
12/31/2017	12	-2	0	1	N/A
9/30/2017	11	-2	N/A	0	N/A
6/30/2017	9	-2	N/A	0	N/A
3/31/2017	8	-2	N/A	-1	N/A
12/31/2016	7	-3	N/A	-2	N/A
9/30/2016	8	-7	N/A	-4	N/A
6/30/2016	7	-8	N/A	-3	N/A
3/31/2016	7	-8	N/A	-4	N/A
12/31/2015	7	-9	N/A	-4	N/A
9/30/2015	5	-5	N/A	-4	N/A
6/30/2015	4	-5	N/A	-4	N/A
3/31/2015	4	-5	N/A	-4	N/A
12/31/2014	4	-5	N/A	-4	N/A
9/30/2014	3	-4	N/A	-3	N/A
6/30/2014	3	-3	N/A	-2	N/A
3/31/2014	3	-2	N/A	-2	N/A
12/31/2013	2	-2	N/A	-1	N/A
9/30/2013	2	-2	N/A	-1	N/A
6/30/2013	2	-3	N/A	-1	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de SMLR es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de SMLR crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de SMLR crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de SMLR crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de SMLR crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SMLR se prevé que sea elevada dentro de 3 años.

Semler Scientific Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased to US$55.00

Semler Scientific Updates Financial Guidance for the Year Ending December 31, 2022

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Consensus EPS estimates fall by 31%

Price target decreased to US$85.00

Recent updates

Semler Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024

Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

New minor risk - Shareholder dilution

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorates as stock falls 18%

Now 25% undervalued after recent price drop

Semler Scientific, Inc. to Report Q4, 2023 Results on Mar 05, 2024

Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?

Investor sentiment improves as stock rises 16%

Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Investor sentiment improves as stock rises 33%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Shareholder dilution

Semler Scientific, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Semler Scientific, Inc. Announces Steps Down of Abbie" Leibowitz as Class II Director

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc., Annual General Meeting, Oct 19, 2023

Semler Scientific, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Investor sentiment improves as stock rises 24%

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 26% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc. Announces Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Price target decreased to US$55.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Semler Scientific Updates Financial Guidance for the Year Ending December 31, 2022

Semler Scientific, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Semler Scientific, Inc., Annual General Meeting, Oct 20, 2022

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Semler Scientific: Growth, Profits, And Valuation Models Support A Buy

Investor sentiment improved over the past week

Semler Scientific, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 31%

Price target decreased to US$85.00

Semler Scientific: A Small Company Solving A Big Problem

Semler Scientific, Inc. to Report Q1, 2022 Results on May 02, 2022

Investor sentiment improved over the past week

Consensus revenue estimates fall by 13%

Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

CEO, Corporate Secretary & Director exercised options and sold US$141k worth of stock

Semler Scientific: Why I'm Buying

Full year 2021 earnings: EPS and revenues miss analyst expectations

Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?

Price target decreased to US$137

CEO, Corporate Secretary & Director exercised options and sold US$136k worth of stock

Semler's Unique Business Model Is Fueling Profitable Growth

CEO, Corporate Secretary & Director exercised options and sold US$148k worth of stock

Semler Scientific, Inc. to Report Q4, 2021 Results on Feb 28, 2022

CEO, Corporate Secretary & Director exercised options and sold US$149k worth of stock

CEO, Corporate Secretary & Director exercised options and sold US$140k worth of stock

CEO, Corporate Secretary & Director exercised options and sold US$149k worth of stock

Better Price For Semler Is Likely

Investor sentiment deteriorated over the past week

Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem

Third quarter 2021 earnings released: EPS US$0.61 (vs US$0.74 in 3Q 2020)

Investor sentiment deteriorated over the past week

It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers

Semler Scientific: Rapidly Growing Medical Device Company

There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump

Price target increased to US$167

Semler Scientific, Inc. to Report Q4, 2020 Results on Mar 01, 2021